Facebook Linkedin Twitter
Inside Precision Medicine Five Features Underlie Immunotherapy Response

Chemotherapy

Home Oncology, CIPN
News & Features

Five Features Underlie Immunotherapy Response

Anita Chakraverty -
0
Black male cancer patient reviews results with young, white female doctor. Black patients are more likely to have the Duffy null blood type which may unnecessarily exclude them from cancer clinical trials
News & Features

Cancer Trials Exclude Individuals of African and Middle Eastern Ancestry Due to Duffy Blood Group

Helen Albert -
0
Bald Woman Receiving Chemotherapy Treatment
News & Features

Gastrointestinal Chemotherapy Tweak Can Reduce Side Effects

Anita Chakraverty -
0
Brain Tumor
News & Features

New Glioma Drug Approved for First Time in Decades

Malorye Branca -
0
Sarcoma cells
News & Features

First Engineered T Cell Therapy for Solid Tumors Approved by the FDA

Chris Anderson -
0
Colon cancer. Cancer attacking cell. Colon disease concept
News & Features

Novel Two Drug Approach for Tough-to-Treat Colorectal Cancer 

Malorye Branca -
0
CD20 antigen target
News & Features

Bispecific Antibody Provides Long-Term Responses in Some Advanced Cervical Cancers

Alice McCarthy -
0
Acute myeloid leukemia (AML)
News & Features

New Therapeutic Target Found for Acute Myeloid Leukemia

Chris Anderson -
0
HIV viruses, illustration
News & Features

Second HIV Patient “Cured” with Stem Cell Transplant at Charité, Using Slightly Different Genetic Recipe

Malorye Branca -
0
woman lymph armpit examination. Node-Positive Breast Cancer
News & Features

Gene-Based Model Predicts Taxane Side Effects in Breast Cancer Treatment

Malorye Branca -
0
123...27Page 1 of 27

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine